A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or prison.
Service Response and Content Removal
According to TikTok, the service has removed problematic material and prohibited related hashtags and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.
Online Trading Operations
Investigations also discovered groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, populated with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at residence.
Within moments of joining one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or past usage.
Product Details and Pricing
Inside these communities, messages show black plastic parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for Telegram said it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly serious health risks”.
